Sayas Pharma Private Limited, a active private limited company, was established on 23 October 2018 in Haveli, Maharashtra, India. Engaging in drug formulation & development within the trade sector, it holds CIN: U24304PN2018PTC179752. Registered under ROC Roc Pune. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
Its leadership includes Archana Santosh Jagtap (Additional Director), Bipin Krishnarao Mahajan (Additional Director), Shivaji Muktaji Gadade (Director). Past directors included Yogesh Eknath Walgude, Harshad Bharat Chavan. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Shop No 03 S No 26/2/1 Sitai Complex, Opp Canara Bank Haveli, Haveli, Maharashtra, 411041.
U24304PN2018PTC179752
179752
23 October 2018
₹0.10 M
₹0.10 M
Roc Pune
Unlisted
Active
Explore comprehensive insights into Sayas Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Archana Santosh Jagtap | Additional Director | 30 Nov 2022 | Current |
| Bipin Krishnarao Mahajan | Additional Director | 30 Nov 2022 | Current |
| Shivaji Muktaji Gadade | Director | 23 Oct 2018 | Current |
| Ngangbam Surbala Devi | Additional Director | 06 Feb 2025 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 01 Sep 2022 | Past |
| Pramod Abcsdd | Director | 20 May 2024 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Sayas Pharma Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 70.73% decrease. The company also saw a substantial fall in profitability, with a 63.92% decrease in profit. The company's net worth Soared by an impressive increase of 28.11%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2022, Sayas Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Sayas Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Sayas Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sayas Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Ngangbam Surbala Devi was appointed as a Additional Director was appointed as a Additional Director on 06 Feb 2025 & has been associated with this company since 10 months 11 days . was recorded as a recent event.
The activity Sayas Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
Sayas Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Pune. was recorded as a recent event.
Progress on Archana Santosh Jagtap was appointed as a Additional Director was appointed as a Additional Director on 30 Nov 2022 & has been associated with this company since 3 years 19 days . was documented.
Bipin Krishnarao Mahajan was appointed as a Additional Director was appointed as a Additional Director on 30 Nov 2022 & has been associated with this company since 3 years 19 days . was recorded as a recent event.
Progress on Shivaji Muktaji Gadade was appointed as a Director was appointed as a Director on 23 Oct 2018 & has been associated with this company since 7 years 1 month . was documented.
The CIN of Sayas Pharma Private Limited is U24304PN2018PTC179752.
Sayas Pharma Private Limited is headquartered at Shop No 03 S No 26/2/1 Sitai Complex, Opp Canara Bank Haveli, Haveli, Maharashtra, 411041.
Sayas Pharma Private Limited was incorporated on 23 October 2018.
The current directors of Sayas Pharma Private Limited are
The primary industry of Sayas Pharma Private Limited is Trade.
Sayas Pharma Private Limited is unlisted.
The authorized capital of Sayas Pharma Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX